Health Care

Lisa Gill, who spent the past two years at No. 2, rises the final rung to capture the crown for the first time. The J.P. Morgan analyst is “indispensable when it comes to the pharmacy benefit managers,” insists one longtime supporter.

Six-time sector king Mark Schoenebaum juggled that mandate while moving from Deutsche Bank Securities to ISI Group, which he joined in June.

For a sixth year in a row, Adam Feinstein of Barclays Capital captures the crown, thanks in part to his “brilliant and detailed analysis of what health care reform really means for these companies,” as one money manager puts it.

In a year when health care reform moved from a relatively dim prospect to a fait accompli, the buy side turned to seven-time sector champion John Rex of J.P. Morgan to understand what Washington would do to the insurance industry — or even whether managed care would survive at all.

J.P. Morgan’s Michael Weinstein makes it four in a row in the top spot, thanks in part for being “a really nice guy — but reliably no-­nonsense.

Derik de Bruin of UBS debuts in the top spot in this new sector, which inched up 1.7 percent in the 12 months through August (and trailed the broad market by 1.1 percentage points).